AgeX Therapeutics
| AgeX Therapeutics | |
|---|---|
| Тип | публичная |
| Дата основания | 2017 |
| Основатели | Майкл Вест () |
| Расположение | Аламида, Калифорния, США |
| Ключевые фигуры | Майкл Вест (CEO),; Обри ди Грей ( по созданию новых технологий) |
| Отрасль | Биотехнологии,; исследование старения |
| Сайт | agexinc.com |
AgeX Therapeutics (часто сокращаемая до AgeX) — американская биотехнологическая компания, разрабатывающая подходы к человеческому долголетию. Компания была основа в 2017 году, первоначально как филиал компании BioTimeen, при поддержке британского миллиардера-инвестора Джима Меллонаen и других.
Вице-президентом компании по созданию новых технологий стал Обри ди Грей, который также является директором по науке () Исследовательского фонда SENS. Председателем является Gregory Bailey, работавший прежде одним из руководителей компании Medivationen, пока та не была приобретена фармацевтическим гигантом Pfizer в 2016 году за 14 миллиардов долларов.
В январе 2020, AgeX Therapeutics объявило исследовательское сотрудничество с японской биофармацевтической фирмой для создания гипоиммунных клеток на базе технологической платформы AgeX.
Примечания
- Graham Lawton: Anti-ageing drugs are coming that could keep you healthier for longer — https://www.newscientist.com/article/mg24232270-100-anti-ageing-drugs-are-coming-that-could-keep-you-healthier-for-longer
- https://www.newscientist.com/article/mg24232270-100-anti-ageing-drugs-are-coming-that-could-keep-you-healthier-for-longer
- https://web.archive.org/web/20210417194204/https://www.newscientist.com/article/mg24232270-100-anti-ageing-drugs-are-coming-that-could-keep-you-healthier-for-longer/
- Brian Wang: AgeX to develop powerful regenerative and anti-aging treatments — https://www.nextbigfuture.com/2017/12/agex-to-develop-powerful-regenerative-and-anti-aging-treatments.html
- https://www.nextbigfuture.com/2017/12/agex-to-develop-powerful-regenerative-and-anti-aging-treatments.html
- https://web.archive.org/web/20210422100249/https://www.nextbigfuture.com/2017/12/agex-to-develop-powerful-regenerative-and-anti-aging-treatments.html
- John Carroll: British billionaire Jim Mellon and high-profile partners roll the dice on an anti-aging upstart — https://endpts.com/british-billionaire-jim-mellon-and-high-profile-partners-roll-the-dice-on-an-anti-aging-upstart/
- https://endpts.com/british-billionaire-jim-mellon-and-high-profile-partners-roll-the-dice-on-an-anti-aging-upstart/
- https://web.archive.org/web/20210416115024/https://endpts.com/british-billionaire-jim-mellon-and-high-profile-partners-roll-the-dice-on-an-anti-aging-upstart/
- Juvenescence aims to tap longevity ‘money fountain’ — https://www.ft.com/content/30bb0752-6d5e-11e8-92d3-6c13e5c92914
- https://www.ft.com/content/30bb0752-6d5e-11e8-92d3-6c13e5c92914
- https://web.archive.org/web/20210416115023/https://www.ft.com/content/30bb0752-6d5e-11e8-92d3-6c13e5c92914
- Executive team — https://www.sens.org/about-us/leadership/executive-team/
- https://www.sens.org/about-us/leadership/executive-team/
- https://web.archive.org/web/20210416140330/https://www.sens.org/about-us/leadership/executive-team/
- Andrew Pollack, Leslie Picker: Pfizer to Buy Cancer Drug Maker in $14 Billion Deal — https://www.nytimes.com/2016/08/23/business/dealbook/medivation-pfizer-14-billion-deal.html
- https://www.nytimes.com/2016/08/23/business/dealbook/medivation-pfizer-14-billion-deal.html
- https://web.archive.org/web/20210416115023/https://www.nytimes.com/2016/08/23/business/dealbook/medivation-pfizer-14-billion-deal.html
- AgeX Therapeutics Enters Research Collaboration With Japanese Biopharma Company to Generate Hypoimmunogenic Cells — https://finance.yahoo.com/news/agex-therapeutics-enters-research-collaboration-130000793.html
- https://finance.yahoo.com/news/agex-therapeutics-enters-research-collaboration-130000793.html
- https://web.archive.org/web/20200224061016/https://finance.yahoo.com/news/agex-therapeutics-enters-research-collaboration-130000793.html